Improving the quality of care in the molecular era for children and adolescents with medulloblastoma

Purpose Elevated mortality and morbidity rates persist in pediatric patients with medulloblastoma. We present a clinical audit of a real-world cohort of patients in search for pragmatic measures to improve their management and outcome.